Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |